15631-2307 NDC - BELLADONNA ()

Drug Information

Field Name	Field Value
Labeler Name:	Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
Product Type:
FDA Application Number:
Marketing Category:	UNAPPROVED HOMEOPATHIC
Start Marketing Date:	3/30/2016

No.	Package Code	Package Description
1	15631-2307-0	1 CONTAINER in 1 CONTAINER (15631-2307-0) / 50 g in 1 CONTAINER
2	15631-2307-1	1 CONTAINER in 1 CONTAINER (15631-2307-1) / 100 g in 1 CONTAINER
3	15631-2307-2	1 CONTAINER in 1 CONTAINER (15631-2307-2) / 200 g in 1 CONTAINER
4	15631-2307-3	1 CONTAINER in 1 CONTAINER (15631-2307-3) / 500 g in 1 CONTAINER

Field Name	Field Value	Definition
PRODUCT NDC	15631-2307	The translation of the route code submitted by the firm, indicating route of administration.
PROPRIETARY NAME	BELLADONNA	This is the date that the labeler indicates was the start of its marketing of the drug product.
START MARKETING DATE	3/30/2016	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	UNAPPROVED HOMEOPATHIC	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.